ImmunologybioRxiv
Development and optimisation of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures
W. Chiu, L. Verschueren, C. Van den Eynde…·E. Van Damme
The paper develops a high-throughput screening assay to evaluate 5676 phase 1 compounds for in vitro anti-SARS-CoV-2 activity, identifying eight candidates but finding only remdesivir suitable for further clinical development.
DOI 10.1002/jmv.27683